Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
147 studies found for:    CELIAC DISEASE
Show Display Options
Rank Status Study
21 Completed A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
22 Recruiting Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment.
Condition: Celiac Disease
Interventions: Dietary Supplement: rusks made of wheat flour enzymatically treated;   Dietary Supplement: rusks made of wheat flour not enzimatically modified;   Dietary Supplement: Gluten-free diet
23 Completed Oral AGY for Celiac Disease
Condition: Celiac Disease
Intervention: Other: AGY
24 Not yet recruiting Hookworm Therapy for Coeliac Disease
Condition: Celiac Disease
Interventions: Other: Gluten micro-challenge;   Other: Inadvertent gluten challenge;   Other: Moderate gluten challenge;   Other: Liberal diet;   Other: Necator americanus-hookworm larvae L3-10;   Other: Tabasco® Sauce;   Other: Necator americanus-hookworm larvae L3-20;   Other: Gluten free diet
25 Completed
Has Results
Desensitising Celiac Disease Patients With the Human Hookworm
Condition: Celiac Disease
Intervention: Biological: Necator americanus
26 Recruiting Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial
Conditions: Celiac Disease;   Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Gluten Free Diet
27 Completed Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
Conditions: Celiac Disease;   Non-celiac Gluten Sensitivity
Interventions: Dietary Supplement: Gluten challenge;   Dietary Supplement: Placebo challenge
28 Active, not recruiting Study of Enzyme Supplements to Treat Celiac Disease
Conditions: Celiac Disease;   Dermatitis Herpetiformis
Interventions: Drug: STAN1;   Drug: Placebo enzyme;   Drug: STAN1+gluten
29 Terminated Response to Hepatitis B Vaccine in Celiac Disease Patients
Condition: Celiac Disease
Intervention: Biological: hepatitis B vaccine (EngerixB)
30 Recruiting Celiac Disease Diagnosis in Patients With Weakly Positive Serum Anti-Transglutaminase: Duodenal Anti-Endomysium Assay.
Condition: Celiac Disease
Intervention:
31 Not yet recruiting Choosing a Preferred Serology Kit for Screening and Diagnosis of Celiac Disease
Condition: Celiac Disease
Intervention:
32 Completed Inoculating Celiac Disease Patients With the Human Hookworm Necator Americanus: Evaluating Immunity and Gluten-sensitivity
Condition: Celiac Disease
Interventions: Biological: Necator americanus;   Other: Sham inoculation
33 Completed Clinical Trial on the Effects of Bifidobacterium Infantis in Active Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Probiotic
34 Completed Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Triticum monococcum
35 Completed Protocol for Correlating Enteropathic Severity and Small Intestinal CYP3A4 Activity in Patients With Celiac Disease
Condition: Celiac Disease
Intervention: Drug: Simvastatin
36 Completed Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: AT-1001;   Drug: placebo
37 Completed Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide acetate (AT1001);   Drug: Placebo
38 Completed Evaluate the Use of Optical Frequency Domain Imaging (OFDI) for Celiac Disease in Children, Adolescents and Young Adults
Condition: Celiac Disease
Intervention: Device: MGH OFDI Imaging
39 Completed Saliva Composition and Oral Hygiene in Children With Celiac Disease Before and After the Change in Diet
Condition: Celiac Disease
Intervention:
40 Completed A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Condition: Celiac Disease
Intervention: Drug: 4 dose levels of ALV003

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years